AMR Logo.png
Biotech Ingredients Market Size to Reach $75.3 Billion by 2028 | CAGR: 4.8%: AMR
14 juin 2021 10h36 HE | Allied Market Research
Portland, OR, June 14, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global biotech ingredients market was pegged at $51.3 billion in 2020 and is...
sandos-logo.jpg
US Supreme Court denies Sandoz petition to review biosimilar Erelzi® (etanercept-szzs) case
17 mai 2021 10h44 HE | Novartis Pharma AG
Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of more affordable Erelzi treatment option for US patients Sandoz is disappointed US patients affected by...
New ACR White Paper Highlights Health Care Challenges Affecting the Rheumatic Disease Community
12 mai 2021 12h28 HE | American College of Rheumatology
Atlanta, May 12, 2021 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) today announced the launch of a new white paper, “Rheumatic Diseases in America: Confronting the Challenge,”...
Coherus BioSciences, Inc. logo
Coherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for Review
17 févr. 2021 07h30 HE | Coherus BioSciences, Inc.
REDWOOD CITY, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: “CHRS”, “the Company”, “Coherus”) announced that the United States Food and Drug Administration (“FDA”) has...
ERIC Releases Groundbreaking Research Showing Significant Savings from Biosimilars
07 avr. 2020 11h14 HE | The ERISA Industry Committee
Washington, DC, April 07, 2020 (GLOBE NEWSWIRE) -- The ERISA Industry Committee (ERIC) released groundbreaking research, part of a larger initiative examining the impact of biosimilars on the health...
Reports and Data.jpeg-01
Ulcerative Colitis Drug Market To Reach USD 10.25 Billion By 2027 | Reports And Data
03 févr. 2020 15h00 HE | Reports and Data
New York, Feb. 03, 2020 (GLOBE NEWSWIRE) -- The global ulcerative colitis drug market is forecast to reach USD 10.25 Billion by 2027, according to a new report by Reports and Data. Ulcerative...
Community Oncology Alliance Releases Six New Position Statements
18 sept. 2019 12h50 HE | Community Oncology Alliance
Washington, DC, Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Community Oncology Alliance (COA) Board of Directors approved six new Position Statements for public release. A unanimous vote at this week’s...
Fior-Markets-Logo.jpg
Global Erythropoietin Drugs Market is Expected to Reach USD 18.67 Billion by 2025 : Fior Markets
26 août 2019 08h12 HE | Fior Markets
New Jersey, NJ, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Rising prevalence of anaemia caused due to chronic diseases such as cancer, HIV AIDS, chronic kidney disease is driving the global demand for the...
Erythropoietin (EPO) Drugs Market To Cross USD 12 billion by 2020 | Reports And Data
24 juil. 2019 09h51 HE | Reports and Data
New York, July 24, 2019 (GLOBE NEWSWIRE) -- This report on the Erythropoietin (EPO) Drugs market offers an extensive analysis of the trends to estimate its growth in the near future. It provides...
finalGSRLarge.jpg
Global Biosimilars Market Is Estimated to Grow at a CAGR of +6% by 2025 Top Companies are Pfizer, Sandoz, Teva Pharmaceuticals, Amgen, Biocon, Dr. Reddy’s Laboratories, Celltrion
05 juil. 2019 05h50 HE | Global Reports Store
PUNE, India, July 05, 2019 (GLOBE NEWSWIRE) -- Global Biosimilars Industry was valued at USD $7.75 Billion in the year 2019. Global Biosimilars Industry is further estimated to grow at a CAGR of...